Carregant...
Current progress in stem cell therapy for type 1 diabetes mellitus
Type 1 diabetes mellitus (T1DM) is the most common chronic autoimmune disease in young patients and is characterized by the loss of pancreatic β cells; as a result, the body becomes insulin deficient and hyperglycemic. Administration or injection of exogenous insulin cannot mimic the endogenous insu...
Guardat en:
| Publicat a: | Stem Cell Res Ther |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7346484/ https://ncbi.nlm.nih.gov/pubmed/32641151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01793-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|